Bill > SB0199

This bill requires certain health care providers to provide specific written disclosures to patients before administering stem cell therapy that has not been approved by the US Food and Drug Administration (FDA). The bill defines key terms, such as "health care provider," "stem cell therapy," and "human cells, tissues, or cellular or tissue-based products." It outlines the requirements for the written notice, including the font size and placement, as well as the required content of the patient consent form. The bill also provides exceptions for health care providers who have obtained FDA approval or are performing stem cell therapy under certain accredited institutions. Violations of the bill's requirements are considered unprofessional conduct.

Health and Social Services

https://le.utah.gov/~2024/bills/static/SB0199.html